Michael Benkowitz
2016
In 2016, Michael Benkowitz earned a total compensation of $5.4M as President and Chief Operating Officer at United Therapeutics.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $508,653 |
|---|---|
| Non-Equity Incentive Plan | $416,000 |
| Option Awards | $3,570,563 |
| Salary | $568,417 |
| Other | $287,522 |
| Total | $5,351,155 |
Benkowitz received $3.6M in option awards, accounting for 67% of the total pay in 2016.
Benkowitz also received $508.7K of change in pension value and nonqualified deferred compensation earnings, $416K in non-equity incentive plan, $568.4K in salary and $287.5K in other compensation.
Rankings
In 2016, Michael Benkowitz's compensation ranked 1,451st out of 14,075 executives tracked by ExecPay. In other words, Benkowitz earned more than 89.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,451 out of 14,075 | 90th |
Division Manufacturing | 491 out of 5,486 | 91st |
Major group Chemicals And Allied Products | 137 out of 1,900 | 93rd |
Industry group Drugs | 93 out of 1,543 | 94th |
Industry Pharmaceutical Preparations | 74 out of 1,173 | 94th |
Source: SEC filing on April 28, 2017.
Benkowitz's colleagues
We found five more compensation records of executives who worked with Michael Benkowitz at United Therapeutics in 2016.
2016
Roger Jeffs
United Therapeutics
Chief Executive Officer
2016
Martine Rothblatt
United Therapeutics
Chief Executive Officer
2016
Paul Mahon
United Therapeutics
General Counsel
2016
James Edgemond
United Therapeutics
Chief Financial Officer
2016
David Zaccardelli
United Therapeutics